Document is current
Any future updates will be listed below
-
Authors
Liu, Kai http://orcid.org/0000-0002-3045-0809
Nilsson, Ralf
Lázaro-Ibáñez, Elisa http://orcid.org/0000-0002-3542-7069
Duàn, Hanna http://orcid.org/0000-0001-8318-130X
Miliotis, Tasso
Strimfors, Marie
Lerche, Michael
Salgado Ribeiro, Ana Rita http://orcid.org/0000-0001-6357-6670
Ulander, Johan
Lindén, Daniel http://orcid.org/0000-0003-4158-8018
Salvati, Anna http://orcid.org/0000-0002-9339-0161
Sabirsh, Alan http://orcid.org/0000-0001-5310-0281
-
Funding
Funding for this research was provided by:
AstraZeneca Postdoc program
- License Information
-
More Information
Article History
Received: 15 July 2022
Accepted: 27 June 2023
First Online: 6 July 2023
Competing interests
: K.L., R.N., E.L.-I., H.D., T.M., M.S., M.L. A.R.S.R., J.U., D.l.L. and A. Sabirsh are or were at the time of work employees of AstraZeneca. Anna Salvati declares no competing interests.
